News

Swedish Orphan Biovitrum chief scientific officer Peter Edman said that the orphan drug designation provides them with valuable regulatory support for the development of Sym001 in ITP that

Watson’s Rasagiline mesylate tablets are generic versions of Teva Neuroscience’s Azilect tablets, which are indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease as

IMCgp100 is the first clinical candidate originating from Immunocore’s ImmTAC technology platform which builds on expertise with T cell receptors and has the potential to target a range

AGP’s new manufacturing facility has been inspected by the Food and Drug Board of Ghana and issued required permits and approval for the importing of raw materials and

The agreement allows Vernalis to receive fees and research milestones and a share in the downstream success of the product in the form of further milestones and royalties

Altravax is expected to use its proprietary MolecularBreeding directed evolution technology to create vaccines that provide protection against the various strains of HIV-1. Altravax has received exclusive rights

Hydrocodone Polistirex and Chlorpheniramine Polistirex (CIII) ER oral suspension is a generic version of UCB’s Tussionex, which is used for relief of cough and upper respiratory symptoms associated

Loxonin gel 1% contains the same active ingredient, loxoprofen sodium hydrate as found in pills and powder formulations of the oral analgesic and anti-inflammatory Loxonin brand. Daiichi Sankyo

The patent application covers the combined use of Ampakine compounds and metabotropic glutamate receptor type 5 (mGluR5) antagonists for the treatment of Fragile X syndrome. The investigators from